跳至主要内容
临床试验/NCT04215770
NCT04215770已完成不适用

Comparison of Intravenous Co-amoxiclav Versus Benzyl Penicillin in Children With Severe Tonsillitis

Combined Military Hospital, Pakistan1 个研究点 分布在 1 个国家目标入组 310 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
310
试验地点
1
主要终点
treatment efficacy

研究概览

简要总结

To compare intravenous Co-amoxiclav versus Benzyl penicillin in children with severe streptococcal tonsillitis in terms of efficacy, safety and cost effectiveness.

详细描述

Efficacy was measured through improvement (decrease in fever, settling lymphadenopathy and disappearance of tonsillar exudate) in Centor Criteria score on daily basis. Improvement i.e reduction in Centor Criteria score was recorded for all children till full recovery.

Safety was measured by frequency of hypersensitivity reactions or severe side effects of antibiotics necessitating stoppage of the drug. All the children in both Groups were given test dose of the antibiotic before giving full dose of antibiotic prescribed.

Cost effectiveness was compared in terms of total cost of injections (Co-amoxiclav versus Benzyl penicillin) which were administered to children in both groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
5 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children who had 3 or 4 score according to Centor Criteria for tonsillitis/pharyngotonsillitis, were included in study
  • Children between ages of 5 to 15 years
  • Children with positive Rapid Antigen detection Test (RADT) for Streptococcus Pyogenes

排除标准

  • Immunocompromised children
  • Children with known hypersensitivity to Penicillins (esp Coamoxiclav and Benzyl penicillin)
  • Children with liver or renal failure
  • Children who were already using any oral or parenteral antibiotics

研究组 & 干预措施

Inj Co-amoxiclav

Active Comparator

Group A children were advised Inj Co-amoxiclav 50 units/kg/day in 3 divided doses daily

干预措施: inj co-amoxiclav 50 units/kg/day vs inj Benzyl Penicillin 25000 units/kg/day (Drug)

Inj Benzyl Penicillin

Active Comparator

Group B patients were advised inj Benzyl Penicillin 25000 units/kg/day in 3 divided doses

干预措施: inj co-amoxiclav 50 units/kg/day vs inj Benzyl Penicillin 25000 units/kg/day (Drug)

结局指标

主要结局

treatment efficacy

时间窗: 10 days

full recovery (Centor score became zero/nil)

次要结局

未报告次要终点

研究者

发起方
Combined Military Hospital, Pakistan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Khan

ENT consultant

Combined Military Hospital, Pakistan

研究点 (1)

Loading locations...

相似试验